INMB
INmune Bio Inc
2.00$
-7.4%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 100.0% | 100.0% | 10.3% | 4.9% | 31.7% | 59.0% | 82.7% | 79.1% | 70.1% | 57.3% | 92.4% | |
| 100.0% | 31.4% | 7.4% | 1.1% | 28.6% | 54.0% | 74.9% | 63.8% | 62.9% | 52.9% | 76.5% | |
| 100.0% | 31.4% | 7.4% | 1.1% | 28.6% | 54.0% | 74.9% | 63.8% | 62.9% | 52.9% | 76.5% | |
| – | 57.7% | 1.8% | 3.7% | 2.6% | 4.4% | 5.5% | 10.3% | 4.3% | 3.6% | 14.0% | |
| – | – | – | – | -3,143.1% | -4,965.1% | -5.5% | 0.0% | – | – | – | |
| – | – | – | – | 0.8% | 0.4% | 0.7% | 0.6% | – | – | – | |
| – | – | 89.7% | 95.1% | 67.5% | 40.6% | 16.5% | 20.2% | 29.0% | 41.7% | – | |
| 258.8% | 133.0% | 1.7% | 4.7% | 3.5% | 4.7% | 19.7% | 26.5% | 33.1% | 18.9% | 27.3% | |
| 258.8% | 133.0% | 1.7% | 4.7% | 2.9% | 4.4% | 4.4% | 13.3% | 32.4% | 18.3% | 26.0% | |
| – | 77.5% | – | – | 0.0% | 0.1% | 0.1% | 6.2% | 17.6% | 0.4% | 1.9% | |
| 6.3% | 48.9% | 0.7% | 3.2% | 1.6% | 3.7% | 3.8% | 6.4% | 13.9% | 16.6% | 24.0% | |
| – | – | – | – | – | – | 14.5% | 11.9% | – | – | – | |
| -158.8% | -33.0% | 98.3% | 95.3% | 96.5% | 95.3% | 80.3% | 73.5% | 66.9% | 81.1% | 72.7% | |
| -411.3% | -72.3% | -6.3% | -78.3% | -86.9% | -82.1% | -63.8% | -111.3% | -212.3% | -412.3% | -646.2% | |
| 42,080.5% | 1,131.1% | 60.9% | 64.6% | 42.0% | 29.5% | 16.1% | 21.9% | 31.5% | 50.4% | 82.2% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.